Biodelivery Sciences International Debt to Equity

The latest debt-to-equity ratio for BDSI is 0.31. That is above the Healthcare sector average of 0.3. Investors often review this figure alongside Biodelivery Sciences International's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BDSI currently prints 0.31 for debt-to-equity ratio, while the sector average sits near 0.3. That is roughly 4.0% above the sector mean. Large gaps often invite a closer look at Biodelivery Sciences International's growth, margins, and balance sheet.

A debt-to-equity ratio of 0.31 for Biodelivery Sciences International is not 'good' or 'bad' on its own. Compare it with the peer average (0.3) and with BDSI's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BDSI's debt-to-equity ratio (0.31), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biodelivery Sciences International's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.